AAVXF
Price
$86.10
Change
+$2.75 (+3.30%)
Updated
Sep 15 closing price
Capitalization
6.59B
MLEC
Price
$0.94
Change
+$0.01 (+1.08%)
Updated
Oct 6, 04:53 PM (EDT)
Capitalization
10.23M
20 days until earnings call
Interact to see
Advertisement

AAVXF vs MLEC

Header iconAAVXF vs MLEC Comparison
Open Charts AAVXF vs MLECBanner chart's image
Abivax SA
Price$86.10
Change+$2.75 (+3.30%)
Volume$200
Capitalization6.59B
Moolec Science SA
Price$0.94
Change+$0.01 (+1.08%)
Volume$500
Capitalization10.23M
AAVXF vs MLEC Comparison Chart in %
AAVXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AAVXF vs. MLEC commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAVXF is a Hold and MLEC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 07, 2025
Stock price -- (AAVXF: $86.10 vs. MLEC: $0.94)
Brand notoriety: AAVXF and MLEC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AAVXF: 85% vs. MLEC: 13%
Market capitalization -- AAVXF: $6.59B vs. MLEC: $10.23M
AAVXF [@Biotechnology] is valued at $6.59B. MLEC’s [@Biotechnology] market capitalization is $10.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AAVXF’s FA Score shows that 1 FA rating(s) are green whileMLEC’s FA Score has 1 green FA rating(s).

  • AAVXF’s FA Score: 1 green, 4 red.
  • MLEC’s FA Score: 1 green, 4 red.
According to our system of comparison, AAVXF is a better buy in the long-term than MLEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AAVXF’s TA Score shows that 2 TA indicator(s) are bullish while MLEC’s TA Score has 5 bullish TA indicator(s).

  • AAVXF’s TA Score: 2 bullish, 4 bearish.
  • MLEC’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, MLEC is a better buy in the short-term than AAVXF.

Price Growth

AAVXF (@Biotechnology) experienced а 0.00% price change this week, while MLEC (@Biotechnology) price change was -12.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.91%. For the same industry, the average monthly price growth was +14.77%, and the average quarterly price growth was +84.62%.

Reported Earning Dates

MLEC is expected to report earnings on Oct 27, 2025.

Industries' Descriptions

@Biotechnology (+6.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AAVXF($6.6B) has a higher market cap than MLEC($10.2M). AAVXF YTD gains are higher at: 679.186 vs. MLEC (-88.254). MLEC has higher annual earnings (EBITDA): -5.24M vs. AAVXF (-170.04M). AAVXF has more cash in the bank: 104M vs. MLEC (926K). MLEC has less debt than AAVXF: MLEC (22.1M) vs AAVXF (92.6M). MLEC has higher revenues than AAVXF: MLEC (7.83M) vs AAVXF (0).
AAVXFMLECAAVXF / MLEC
Capitalization6.6B10.2M64,657%
EBITDA-170.04M-5.24M3,243%
Gain YTD679.186-88.254-770%
P/E RatioN/AN/A-
Revenue07.83M-
Total Cash104M926K11,231%
Total Debt92.6M22.1M419%
FUNDAMENTALS RATINGS
AAVXF: Fundamental Ratings
AAVXF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
26
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AAVXFMLEC
RSI
ODDS (%)
Bearish Trend 4 days ago
54%
Bullish Trend 4 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
42%
Bullish Trend 4 days ago
55%
Momentum
ODDS (%)
Bullish Trend 4 days ago
38%
Bearish Trend 4 days ago
57%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
32%
Bearish Trend 4 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
28%
Bearish Trend 4 days ago
80%
Advances
ODDS (%)
N/A
Bullish Trend 14 days ago
59%
Declines
ODDS (%)
Bearish Trend 26 days ago
67%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
47%
Bullish Trend 4 days ago
69%
Aroon
ODDS (%)
Bullish Trend 4 days ago
40%
Bearish Trend 4 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
AAVXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CURR1.650.08
+5.10%
Currenc Group Inc
GPRE10.030.38
+3.94%
Green Plains
HCM16.210.12
+0.75%
HUTCHMED (China) Limited
CVR10.21N/A
N/A
Chicago Rivet & Machine Co
CNC37.64-1.06
-2.74%
Centene Corp

AAVXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AAVXF has been loosely correlated with BPMUF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AAVXF jumps, then BPMUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AAVXF
1D Price
Change %
AAVXF100%
N/A
BPMUF - AAVXF
47%
Loosely correlated
N/A
MLEC - AAVXF
38%
Loosely correlated
+1.04%
CNSP - AAVXF
34%
Loosely correlated
+5.85%
ACHV - AAVXF
28%
Poorly correlated
+0.32%
GMAB - AAVXF
24%
Poorly correlated
-0.74%
More

MLEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLEC has been loosely correlated with SPRB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MLEC jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLEC
1D Price
Change %
MLEC100%
+1.04%
SPRB - MLEC
51%
Loosely correlated
+1378.46%
CTMX - MLEC
42%
Loosely correlated
-0.61%
AAVXF - MLEC
38%
Loosely correlated
N/A
ABEO - MLEC
36%
Loosely correlated
-1.29%
ABVC - MLEC
31%
Poorly correlated
+4.33%
More